Company news
IRIDEX Corporation news in 2024
IRIDEX Corporation's news releases, calls and decks from 2024, newest first.
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
December 17, 2024
Iridex Reports Third Quarter 2024 Financial Results
November 11, 2024
Iridex Appoints Patrick Mercer as Chief Executive Officer
October 2, 2024
Iridex Reports Second Quarter 2024 Financial Results
August 7, 2024
Iridex Announces Convertible Note Financing
August 4, 2024
Iridex Reports First Quarter 2024 Financial Results
May 13, 2024
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
May 7, 2024
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
March 25, 2024
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
March 19, 2024
Iridex Corporation Receives European Patent on MicroPulse Technology
February 5, 2024
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
January 23, 2024
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
January 10, 2024